HCV Clearance Linked to Better Outcomes in African Americans with Aggressive Lymphoma Tops SPT Week in Review

5. Tofacitinib Receives FDA Approval for Treatment of Ulcerative Colitis

Tofacitinib is indicated for the treatment of adult patients with severely active ulcerative colitis, severely active rheumatoid arthritis, or psoriatic arthritis. Read more.

4. CVS Health’s Transform Oncology Care Leads Patients with Late-Stage Cancer to Appropriate Treatment Plan

CVS Health has announced the launch of Transform Oncology Care, a precision medicine strategy in oncology management for payers. Read more.

3. First Orally Administered Paclitaxel Shown to Be More Effective than Intravenous Paclitaxel for Metastatic Breast Cancer

Patients with metastatic breast cancer who received an oral formulation of the chemotherapy drug paclitaxel (Taxol) had a better response and survival and less neuropathy than patients who received intravenous paclitaxel. Read more.

2. Estrogen Alone Decreases, Adding Progestin Increases Incidence of Breast Cancer in Postmenopausal Women

Despite the fact that menopausal hormone therapy with estrogen plus progestin is frequently used, its influence on breast cancer incidence and mortality has been debated, with discordant findings from prospective observational studies. Read more.

1. HCV Clearance Linked to Better Outcomes in African Americans with Aggressive Lymphoma

Clearance of hepatitis C virus in African American patients with lymphoma, including those with aggressive B-cell non-Hodgkin lymphoma, is associated with improved outcomes. Read more.